Companies: 10,795·Total market cap: $144.5T

Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc.

LRMRNASDAQHealthcare● Active

$3.15

$-0.02(-0.63%)

Market Cap$269570864

P/E Ratio—

52W High$6.42

52W Low$2.22

Avg Volume1.8M

Open$3.21

Beta0.82

Net Income Financials Revenue

Larimar Therapeutics, Inc. (LRMR) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

LRMR · net income · updated Jun 8, 2026

Core profitability metrics

LRMR · net income · margin · TTM · CAGR

Net income was −$165.7M for FY2025 (fiscal year ending 2025-12-31), down 105.5% year-over-year. Net profit margin was —.

FY2025 Net Income−$165.7M▼ -105.5% YoY

Trailing 12M (TTM)−$166.0Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change-105.5%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · LRMR net income history · LRMR profit margin

Annual net income data

LRMR · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$165.7M▼ 105.5%—$0

FY2024Loss−$80.6M▼ 118.1%—$0

FY2023Loss−$36.9M▼ 4.5%—$0

FY2022Loss−$35.4M▲ +30.2%—$0

FY2021Loss−$50.6M▼ 19.6%—$0

Net income vs peers (Healthcare)

LRMR vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Larimar Therapeutics, Inc.YOU

LRMR

−$165.7M-105.5%—

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Larimar Therapeutics, Inc. (LRMR) reported net income of −$165.7M for FY2025 (fiscal year ending 2025-12-31), down 105.5% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Larimar Therapeutics, Inc. has not yet achieved annual profitability based on available data (15 fiscal years). The company has reported net losses across all available periods.

Larimar Therapeutics, Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Larimar Therapeutics, Inc. net worth" — the company's market capitalization is a separate figure from LRMR net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

LRMR net income · 4 questions

Larimar Therapeutics, Inc. is not currently profitable on an annual basis. The company reported a net loss of $165.7M for FY2025.

is LRMR profitabledoes LRMR make a profitLRMR profitabilityLRMR profitable company

▸ Source: FMP /income-statement · GAAP · Larimar Therapeutics, Inc. · Larimar Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026